October 1, 2019
Eisai and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic business in China, the companies said on September 30. Eisai’s Chinese subsidiary will market the products of Nichi-Iko, which will make the first foray into the...read more